Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer's Motion to Dismiss Certain Cases

Bernstein Liebhard LLP, which is currently representing clients in the federal Lipitor proceeding, reports that the Court has granted Pfizer's Motion, and has dismissed four individual Lipitor lawsuits without prejudice.

New York, New York (PRWEB) March 27, 2015

The federal court overseeing thousands of Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that allege the statin medication increases the risk that a patient will develop Type 2 diabetes has granted Pfizer Inc.'s Motion to Dismiss four individual cases that had been filed in the proceeding. According to a Case Management Order issued in the U.S. District Court, District of South Carolina, on March 23rd, the Court determined that the dismissals were warranted because the plaintiffs in those claims had not complied with certain discovery orders. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

"The Court did dismiss these claims without prejudice, which means that plaintiffs will be permitted to refile their cases, so long as they comply with stipulations set forth in the Order. It's important to note that this decision impacts only the four individual claims identified by the Court, and will have no effect whatsoever on the thousands of other Lipitor lawsuits currently pending in the District of South Carolina," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing clients in the federal proceeding, and continues to offer free and confidential case reviews to individuals who may have been harmed by Lipitor.

Lipitor Products Liability Litigation
More than 2,000 Lipitor lawsuits are now pending in the federal litigation underway in South Carolina. According to court documents, the cases were filed in the wake of an alert issued by the U.S. Food & Drug Administration (FDA) in February 2012, which warned that cholesterol-lowering statins like Lipitor might be associated with an increased risk of new-onset Type 2 diabetes. At the time, the agency disclosed that it would require that new information be added to the labels of Lipitor and other statins regarding their potential effect on blood glucose levels.

Court records indicate that all of the pending claims accuse Pfizer of concealing the link between Lipitor and diabetes, and of failing to warn doctors and patients of this possible side effect. Plaintiffs further allege that the information added to the Lipitor label in the wake of the FDA's 2012 mandate still does not adequately warn patients about the drug's association with diabetes.

Lipitor patients who allegedly developed Type 2 diabetes due to the medication may be entitled to compensation for medical bills, lost wages, pain and suffering, and other injury related damages. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP's website. To arrange for a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have ben able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.lipitorlawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

For the original version on PRWeb visit: http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12615228.htm